Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Healix (503B Compounding Pharmacy Services Division)

Healix (503B Compounding Pharmacy Services Division)
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of compounded sterile preparation services. The company provides high-quality, ready-to-use compounded sterile preparations to hospitals across the country through its manufacturing facility that is registered with the U.S. Food and Drug Administration (FDA) as an Outsourcing Facility under Section 503B of the Federal Food, Drug, and Cosmetic Act.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 14140 Southwest Freeway
  • Suite 400
  • Sugar Land, TX 77478
  • United States

Healix (503B Compounding Pharmacy Services Division) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Healix (503B Compounding Pharmacy Services Division)‘s full profile, request access.

Request full access to PitchBook

Healix (503B Compounding Pharmacy Services Division) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Healix (503B Compounding Pharmacy Services Division)‘s full profile, request access.

Request full access to PitchBook